NCT04904588 2026-03-18ACCESSCenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting300 enrolled
NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT00582933 2016-02-01Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorMemorial Sloan Kettering Cancer CenterPhase 2 Completed96 enrolled 5 charts